AML On The Go - Phase IB/III Study of Nivolumab in Combination with
AML On The Go - 01
SOHO 2017
AML On The Go - Phase IB/III Study of Nivolumab in Combination with 5-Azacytidine (AZA) in Patient (PTS) with Relapsed Acute Myeloid Leukemia (AML)
Naval G. Daver, MD
Associate Professor
Department of Leukemia
Divison of Cancer Medicine
The University of Texas
MD Anderson Cancer Center